Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

• Main Authors: Mao S (Author), Zhang J (Author), Guo Y (Author), Zhang Z (Author), Wu Y (Author), Zhang W (Author), Wang L (Author), Jiang Geng (Author), Yan Y (Author), Yao X (Author)
• Format: Book
• Published: Dove Medical Press, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Shiyu Mao,1,* Junfeng Zhang,1,* Yadong Guo,1,* Ziwei Zhang,1 Yuan Wu,2 Wentao Zhang,2 Longsheng Wang,1 Jiang Geng,1 Yang Yan,1 Xudong Yao1 1Department of Urology, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, PR China; 2Department of Urology, Shanghai Tenth People&a...